ASCP Resident Review Mini-Course Series Session 2: Renal and Soft Tissue Pathology. Carole Vogler MD, FASCP Ema Dragoescu MD

Similar documents
Molecular pathology in soft tissue tumors. Sylvia Höller Pathologie

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction

Klinisch belang van chromosomale translocatie detectie in sarcomen

5/10. Pathology Soft tissue tumors. Farah Bhani. Mohammed Alorjani

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction

Selected Pseudomalignant Soft Tissue Tumors of the Skin and Subcutis

1/10/2018. Soft Tissue Tumors Showing Melanocytic Differentiation. Overview. Desmoplastic/ Spindle Cell Melanoma

Contents Part I Introduction 1 General Description 2 Natural History: Importance of Size, Site, Histopathology

Tumores de células pequeñas, redondas y azules: diagnóstico diferencial cuando el tiempo apremia

Diplomate of the American Board of Pathology in Anatomic and Clinical Pathology

Cutaneous Mesenchymal Neoplasms with EWSR1 Rearrangement

Evening Specialty Conference Bone and Soft Tissue Pathology. Diagnostic pitfalls in bone and soft tissue pathology

Spindle Cell Lesions Of The Breast. Emad Rakha Professor of Breast Pathology and Consultant Pathologist

Slide Seminar Spanish Society of Pathology

Malignant Peripheral Nerve Sheath Tumor

Financial disclosures

Mayo Medical Laboratories

Newer soft tissue entities

The Relevance of Cytologic Atypia in Cutaneous Neural Tumors

INDEX. in this web service Cambridge University Press

Conceptual Evolution of Soft Tissue Tumors Classification

A 25 year old female with a palpable mass in the right lower quadrant of her abdomen

Update on Cutaneous Mesenchymal Tumors. Thomas Brenn

Financial disclosures

Financial disclosures

Surgical Pathology Evening Specialty Conference USCAP 2015

Rhabdomyomas and Rhabdomyosarcomas (RMS) David M. Parham, MD Chief of Anatomic Pathology

3/27/2017. Disclosure of Relevant Financial Relationships

Enterprise Interest Nothing to declare

Special slide seminar

أملس عضلي غرن = Leiomyosarcoma. Leiomyosarcoma 1 / 5

Update On Lipomatous Tumors: Old Standbys and New Concepts

Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport

HOW MAY THE CLASSIFICATION OF SOFT TISSUE TUMORS EVOLVE?

Disclosure of Relevant Financial Relationships

Fluorescence In Situ Hybridization in the Diagnosis of Soft Tissue Neoplasms: A Review. Munir R. Tanas, MD and John R.

Case 1 10/2/17. Myxoid Soft Tissue Tumors & Tumor-like Lesions. Myxofibro- or Fibromyxo-?: Myxoid Soft Tissue Tumours We Are All Mixed Up About

Diagnostic Approach to Soft Tissue Tumors

Lung Tumor Cases: Common Problems and Helpful Hints

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

IMMUNOHISTOCHEMISTRY IN THE DIAGNOSIS OF SOFT TISSUE TUMORS

Fun with Fat. General Rules. Case

57th Annual HSCP Spring Symposium 4/16/2016

USCAP COMPANION MEETING INTERNATIONAL SOCIETY OF BONE AND SOFT TISSUE PATHOLOGY DENVER, March 2 nd 2008

Classification (1) Classification (3) Classification (2) Spindle cell lesions. Spindle cell lesions of bladder (Mills et al.

ACCME/Disclosures. Everything is spindle - how far can we go with limited FNA material? Everything is spindle how far can we go? Everything is spindle

SOFT TISSUE TUMOR PATHOLOGY: AN UPDATE

Molecular Diagnosis of Soft Tissue Tumors: Avoid Pitfalls

IN THE NAME OF GOD Dr. Kheirandish Oral and maxillofacial pathology

Adipocytic Tumours in children

An Overview of Genital Stromal Tumors

Introduction to Musculoskeletal Tumors. James C. Wittig, MD Orthopedic Oncologist Sarcoma Surgeon

Index. J Juvenile hyaline fibromatosis, 27 Juvenile xanthogranuloma, 57 Juxta-articular myxoma, 152

Notice of Faculty Disclosure

The Impact of Advances in Molecular Genetic Pathology on the. Classification, Diagnosis and Treatment of Selected Soft Tissue

Essential Dermatopathology. Jinah Kim, MD, PhD Department of Pathology and Dermatology Stanford University Medical Center

ACCME/Disclosures ALK FUSION-POSITIVE MESENCHYMAL TUMORS. Tumor types with ALK rearrangements. Anaplastic Lymphoma Kinase. Jason L.

Case 2. Dr. Sathima Natarajan M.D. Kaiser Permanente Medical Center Sunset

78 The Power of Peripheral Blood Smears-Apparent Diagnostic Clues (Part 1) Gene Gulati PhD, SH(ASCP)

Immunohistochemistry in Bone and Soft Tissue Tumors. Sahar Rassi Zankoul, MD

Tumors of Adipose Tissue Tumors Epidemiology Clinical Features. Morphology. Mature Adipocytes Separated by delicate fibrous septa

USCAP Pediatrics Evening Subspecialty Conference 2015

Angiomatoid Fibrous Histiocytoma : A Case Report

Gross appearance of peritoneal cysts. They have a thin, translucent wall and contain a clear fluid.

An Overview of Cutaneous Vascular Neoplasms

Original Articles. Utilization of Fluorescence In Situ Hybridization in the Diagnosis of 230 Mesenchymal Neoplasms. An Institutional Experience

* I have no disclosures or any

The Genetics of Myoepithelial Tumors: salivary glands, soft tissue and bone

Disclosure. Relevant Financial Relationship(s) None. Off Label Usage None MFMER slide-1

Diagnostic Value of Immunohistochemistry in Soft Tissue Tumors

Update on Sarcomas of the Head and Neck. Kevin Harrington

Slide seminar: Soft tissue and bone pathology

PROBLEMS OF PROGNOSTICATION IN SOFT TISSUE TUMOURS. Christopher D.M. Fletcher Brigham and Women s Hospital and Harvard Medical School Boston, MA

16 Nuchal Fibroma and Gardner

Aspen conference on pediatric disease. July through August Bone and Soft Tissue Update. David M. Parham, MD. Rhabdomyoma and rhabdomyosarcoma

Shintaro Sugita *, Hiroko Asanuma and Tadashi Hasegawa

Pediatric Soft Tissue Tumors

Biopsy Interpretation of Spindle cell proliferations of the Serosa

Post-test Self-assessment Cases

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Part 1. Slides 1-38, Rita Alaggio Soft tissue tumors Trondheim 14. mars 2013

SESSION 1: GENERAL (BASIC) PATHOLOGY CONCEPTS Thursday, October 16, :30am - 11:30am FACULTY COPY

Gastrointestinal stromal tumor

Cheryl M. Coffin, M.D. Goodpasture Professor of Pathology, Microbiology, and Immunology Vanderbilt University Nashville, TN, USA

Musculoskeletal Sarcomas

Case E1. Female aged 63 years Right Nephrectomy Two separate tumours Section of each tumour

Neurocutaneous Syndromes. Phakomatoses

Current and future applications of Molecular Pathology. Kathy Walsh Clinical Scientist NHS Lothian

Tumors of the Nervous System

General: Brain tumors are lesions that have mass effect distorting the normal tissue and often result in increased intracranial pressure.

Case 1. Disclosure. Imaging. Clinical history 5/10/2016. USCAP 2016 Annual Meeting Evening Specialty Conference Bone and Soft tissue Pathology

81 Stump the Stars 2011: Problem Cases in Hematopathology. Steven Kroft MD Russell Brynes MD LoAnn Peterson MD Eric Hsi MD Kaaren Reichard MD

CASE REPORT Benign epithelioid peripheral nerve sheath tumour resembling schwannoma

Soft Tissue Sarcomas: Questions and Answers

21/07/2017. Hobnail endothelial cells are not the same as epithelioid endothelial cells

Anaplastic Large Cell Lymphoma (of T cell lineage)

Gene Translocations in Musculoskeletal Neoplasms

Khin Thway, Jayson Wang, Taka Mubako, and Cyril Fisher. 1. Introduction

Particolarità molecolari delle neoplasie sarcomatose: Quale lezione biologica possiamo trarre per tutte le altre neoplasie?

Transcription:

178 2011 ASCP Resident Review Mini-Course Series Session 2: Renal and Soft Tissue Pathology Carole Vogler MD, FASCP Ema Dragoescu MD 2011 Annual Meeting Las Vegas, NV AMERICAN SOCIETY FOR CLINICAL PATHOLOGY 33 W. Monroe, Ste. 1600 Chicago, IL 60603

178 2011 ASCP Resident Review Mini-Course Series Session 2: Renal and Soft Tissue Pathology Brand new to the meeting! The Resident Review Mini-Course series will offer resident attendees an interactive opportunity to test their knowledge, identify their areas of weakness, and hear from nationally acclaimed experts the latest thinking, in-depth insights and practical information in a select number of specialty topic areas within pathology. Six hours of education are planned for the series, formatted as three 2-hour sessions over Friday and Saturday of the meeting. Topics covered include: hematopathology, cytopathology, renal and soft tissue pathology, microbiology, chemistry and transfusion medicine. Sessions will be "question intensive" with case-based, board level questions driving the presentation and then mini-lectures playing a back up role to the support the question series. Audience response systems will be available as the mechanism for allowing faculty to present case questions to session participants, instantaneously review group responses, and then present relevant content to explain the correct answers for each question. Areas of focus for Session 2 are: renal and soft tissue pathology. Test your knowledge of clinical and anatomic pathology in a case-based format six hour course using an audience response system. Board level questions on each of topics will be presented followed by a mini-discussion on the question topic directed by the audience responses to the questions. Highlights in microbiology, clinical chemistry, transfusion medicine, renal biopsy pathology, soft tissue tumors, hematopathology and cytopathology will be presented by experts in each field. FACULTY: Carole Vogler MD, FASCP Ema Dragoescu MD Pathology Residents Certification Support Certification Support 2.0 CME/CMLE Credits Accreditation Statement: The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). Credit Designation: The ASCP designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. ASCP continuing education activities are accepted by California, Florida, and many other states for relicensure of clinical laboratory personnel. ASCP designates these activities for the indicated number of Continuing Medical Laboratory Education (CMLE) credit hours. ASCP CMLE credit hours are acceptable to meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. All ASCP CMLE programs are conducted at intermediate to advanced levels of learning. Continuing medical education (CME) activities offered by ASCP are acceptable for the American Board of Pathology s Maintenance of Certification Program.

American Society of Clinical Pathology Resident Review Mini-Course Session 2 Surgical Pathology: Soft Tissue Ema Dragoescu, M.D. Assistant Professor of Pathology Virginia Commonwealth University Health System Richmond, VA

41 yo female with a 2.2 cm left elbow mass. The following is TRUE: A. This lesion can reach large sizes B. Typically, this is a slow growing process C. Surgical excision is required to control this process D. The cell of origin is endothelium E. Can be confused with a malignant process

Nodular Fasciitis Young adults Upper extremities, trunk, neck Rapid growth + small size Cellular proliferation (myofibroblasts)) + myxoid matrix + mitoses Extravassated RBCs, keloid- like collagen Self-limited limited

Nodular Fasciitis

47 yo man with multiple medical problems presents with an 8.5 cm small bowel mass. What is the diagnosis? A. Gastrointestinal stromal tumor (GIST) B. Intra-abdominal abdominal fibromatosis C. Schwannoma D. Fibrosarcoma E. Inflammatory myofibroblastic tumor

The following is true about the above entity with the EXCEPTION: A. Displays strong nuclear staining with β-catenin. B. May be associated with Gardner syndrome. C. It is distinctly different morphologically and phenotypically from GIST. D. It is typically a well-circumscribed lesion amenable to complete surgical excision. It is related to pelvic fibromatosis.

Gardner Syndrome Autosomal dominant Germline mutation of APC gene (5q) Cutaneous cysts (epidermal or sebaceous) Osteomas (skull and facial bones) Intestinal polyposis (adenomatous polyps) Colorectal carcinoma develops by age 40 years Mesenteric fibromatosis Indistinguishable from fibromatosis at other sites and sporadic cases

Fibromatosis

23 yo man with a 4.0 cm ulcerated skin nodule on the anterior abdominal wall. Tumor consists of uniform, slender fibroblasts arranged in a monotonous storiform pattern and strongly and diffusely positive for CD34. The following is true about this neoplasm with the EXCEPTION: A. This tumor shares similar cytogenetic abnormality with giant cell fibroblastoma B. This tumor has a negligible rate of local recurrence C. Fibrosarcoma can develop in this tumor. D. The cytogenetic abnormality of this tumor leads to overproduction of platelet-derived growth factor beta (PDGF). E. When melanin pigment is present in this neoplasm then it is called Bednar tumor.

3 year old girl with a 2.7 cm superficially located right forearm mass. Representative images from the mass are shown below. Tumor cells are positive for desmin. The most likely diagnosis is: A. Alveolar rhabdomyosarcoma B. Cavernous hemangioma C. Organized thrombus D. Angiomatoid fibrous histiocytoma E. Aneurysmal fibrous histiocytoma

Fibrohistiocytic Tumors of Intermediate Malignancy 1. Dermatofibrosarcoma protuberans (DFSP) 2. Giant cell fibroblastoma 3. Plexiform fibrohistiocytic tumor 4. Angiomatoid fibrous histiocytoma Younger patients Significant risk of local recurrence complete surgical excision Limited risk for regional and distant metastases

Dermatofibrosarcoma Protuberans (DFSP) Early + middle adult life Nodular cutaneous mass Trunk and upper extremities CD34 consistently expressed Supernumerary ring chromosomes 17, 22 Similar to giant cell fibroblastoma Exon 2 of PDGF beta is fused to collagen type 1 gene overproduction of PDGF beta Tyrosine kinase inhibitors

DFSP CD34

Fibrosarcoma in DFSP

Angiomatoid Fibrous Histiocytoma Distinctive tumor of children + young adults Nodular/cystic mass in deep dermis + subcutis Extremities Systemic symptoms (anemia, fever, weight loss)

Angiomatoid Fibrous Histiocytoma 1. Blood-filled cystic spaces 2. Fibrous pseudocapsule with lymphoid cuff 3. Histiocyte-like cells Solid masses in the center Uniform, bland Faint eosinophilic cytoplasm with hemosiderin Desmin, CD99 positive in 50% of cases CD68 + in some of the cells

Angiomatoid Fibrous Histiocytoma

Angiomatoid Fibrous Histiocytoma Desmin Cytogenetics t(12;22)(q13;q12) EWSR1-ATF1 fusion gene Similar Similar to clear cell sarcoma!

57 year old man with a deeply-seated left thigh mass. A representative image is shown. The following is TRUE about this tumor: A. The cell of origin is the chondrocyte. B. It is a rapidly growing tumor. C. Tumor cells frequently express desmin. D. Occasionally tumor cells may express neuroendocrine markers. E. This tumor is associated with t(11;22)(q24;q12) balanced translocation.

Extraskeletal Myxoid Chondrosarcoma Uncommon tumor (<3% of all soft tissue sarcomas) WHO: tumor of uncertain differentiation No convincing evidence that it is cartilaginous Adults Extremities (2/3 are proximal: thigh, popliteal fossa) Deep soft tissue, muscle Slow growing, with risk for local recurrence and metastases

Extraskeletal Myxoid CS

Extraskeletal Myxoid CS

Extraskeletal Myxoid Chondrosarcoma Immunohistochemistry Vimentin + Inconsistent expression: S-100, S EMA, neuroendocrine differentiation Cytogenetics t(9;22)(q22;q12) NOR1 gene is aka CHN, NR4A3 t(9;17)(q22;q11) t(9;15)(q22;q21) EWS-NOR1 (70% of cases) NOR1-RBP56 RBP56 fusion gene NOR1-TAF15 fusion gene

15 yo girl with left scapular mass. Tumor cells are positive for CD99 and negative for desmin, myod1, myogenin,, cytokeratin AE1/AE3, and CD45. What is the most likely diagnosis? A. Alveolar rhabdomyosarcoma B. Biphasic synovial sarcoma. C. Desmoplastic small round cell tumor. D. Ewing sarcoma. E. Small cell osteosarcoma

Which of the following statement is TRUE about the above tumor? A. CD99 expression in this tumor is highly specific and sensitive B. 70-80% of cases express cytoplasmic positivity with FLI1 antibody. C. The most common fusion genes associated with this tumor are EWS-FLI and EWS-ERG ERG. D. Tumor cells may have clear cytoplasm due to abundant lipid content. E. Homer Wright rosettes are never seen in this family of tumors.

Ewing Sarcoma/PNET Tumor Family Neuroectodermal differentiation Rearrangements of EWSR1 gene t(11;22)(q24;q12) t(21;22)(q22;q12) EWSR1-FLI1 fusion gene EWSR1-ERG ERG fusion gene Rare in the soft tissue First-third third decade CD99 + (membranous pattern) very sensitive, not specific

Ewing Sarcoma Tumor Family CD99

19 yo man with a 6.2 cm mass attached to the serosa of transverse colon. Representative image from the tumor is below. Tumor cells were positive for cytokeratin AE1/AE3, desmin (see image) and NSE. The following is true about this tumor with the EXCEPTION: A. This tumor characteristically affects young males. B. Tumor cells consistently show nuclear expression with WT-1. C. This tumor is characterized by t(11;22)(p13;q12). D. CD99 may be expressed by this tumor. E. This tumor derives from mesothelial cells.

Desmoplastic Small Round Cell Tumor Abdominal/pelvic peritoneum Young males Aggressive clinical course Typical histology Immunohistochemistry Epithelial markers Desmin (perinuclear( dot-like pattern) Neural markers WT-1 CD99 (a third of cases) t(11;22)(p13;q12) EWS-WT1 WT1 fusion gene

Desmoplastic Small Round Cell Tumor AE1/AE3 Desmin

Tumour Angiomatoid fibrous histiocytoma Clear cell sarcoma Desmoplastic round cell tumor Extraskeletal myxoid chondrosarcoma Ewing sarcoma/pnet Myxoid round cell liposarcoma Translocation t(12;22)(q13;q12) t(12;22)(q13;q12) t(2;22)(q34;q12) t(11;22)(p13;q12) t(21;22)(q22;q12) t(9;22)(q22;q12) t(11;22)(q24;q12) t(21;22)(q22;q12) t(20;22)(q13;q12) t(2;22)(q33;q12) t(7;22)(p22;q12) t(17;22)(q12;q12) t(2;22)(q31;q12) t(1;22)(p36.1;q12) t(6;22)(p21;q12) t(12;22)(q13;q12) Fusion product EWSR1 ATF1 EWSR1 ATF1 EWSR1 CREB1 EWSR1 WT1 WT1 EWSR1 ERG ERG EWSR1 NR4A3 EWSR1 FLI1 EWSR1 ERG ERG EWSR1 NFATC2 EWSR1 FEV EWSR1 ETV1 ETV1 EWSR1 E1AF E1AF EWSR1 SP3 SP3 EWSR1 ZNF278 EWSR1 POU5FI EWSR1 DDIT3 From Romeo S, Dei Tos AP. Soft tissue tumors associated with EWSR1 translocation. Virchows Arch 2010;456:219-234

Fluorescence In Situ Hybridization (FISH)

The patient is a 58 yo man with a 3.0 cm subcutaneous posterior neck mass (see image below). The following is true with the EXCEPTION: A. This tumor is related to pleomorphic lipoma. B. The spindle cells are CD34 positive. C. This tumor is characterized by loss of 16q. D. This tumor is characterized by giant marker and ring chromosomes. E. This is a benign lesion.

Spindle Cell/Pleomorphic Lipoma Best considered as one entity Characteristic clinical setting (80%) Circumscribed Spindle cells uniform, elongated nuclei, bipolar cytoplasmic processes Pleomorphic cells multinucleated bizarre floret-like like cells Ropey, birefringent collagen Loss of 16q, loss of 13q

Spindle Cell Lipoma CD34

The patient is an 80 yo female with 20.0 cm retroperitoneal mass, depicted in the following images. The following is TRUE: A. This is a pleomorphic lipoma. B. This tumor is characterized by giant marker and ring chromosomes. C. MDM2 immunohistochemical stain is negative in this tumor. D. This tumor has a low rate of local recurrence. E. This tumor does not have the potential to dedifferentiate.

Atypical Lipomatous Tumor/Well- Differentiated Liposarcoma Most common form of LS Late adult life Location Deep muscle of extremities Retroperitoneum Spermatic cord, groin Cytogenetics Giant marker and ring chromosomes amplification of 12q13-15 15 (MDM2, CDK4, SAS genes etc.) IHC: positive for MDM2 and CDK4

44 yo female with a 5.0 cm well-circumscribed intramuscular thigh mass. The most likely diagnosis is: A. Intramuscular myxoma. B. Aggressive angiomyxoma. C. Low-grade myxofibrosarcoma. D. Myxoid liposarcoma. E. Low-grade fibromyxoid sarcoma

The following is TRUE about the above tumor: A. It is the most common type of liposarcoma. B. Round cell liposarcoma is the poorly differentiated variant of this tumor. C. No reciprocal translocations have been described in this tumor. D. Survival is independent on the proportion of round cell component in this tumor. E. The most common site for this tumor is retroperitoneum.

t(12;16)(q13;p11) CHOP (DDIT3)-FUS fusion gene t(12;22) t(12;22) DDIT3-EWSR1 fusion gene

15 months old baby boy with a superficially located right upper arm nodule noted by his mother for a few months. The following is true with the EXCEPTION: A. This represents the infantile variant of myxoid liposarcoma. B. This lesion is characterized by 8q11-13 13 rearrangements. C. PLAG1 rearrangements can be detected by FISH in this tumor. D. This is a benign lesion. E. This is a lesion exclusively seen in infancy and early childhood.

Lipoblastoma During the first 3 yrs of life Unlike myxoid liposarcoma which occurs in adults. Lobules of immature fat separated by fibrous septae Two forms: Circumscribed Diffuse Rearrangements of 8q11-13 13 (PLAG1 gene) HAS2/PLAG1 COL1A2/PLAG1

15 yo F with right upper arm deep soft tissue mass. What is the most likely diagnosis? A. Renal cell carcinoma B. Alveolar soft part sarcoma C. Granular cell tumor D. Metastatic malignant melanoma E. Alveolar rhabdomyosarcoma

The following is true about the above neoplasm, with the EXCEPTION: A. Tumor cells express nuclear staining with TFE3 B. Electron microscopy shows the presence of Birbeck granules C. PASD highlights needle-like like crystals within the cytoplasm of tumor cells D. This neoplasm can metastasize decades after the original diagnosis E. It is characterized by chromosomal translocation that leads to the TFE3-ASPSCR1 fusion gene

Alveolar Soft Part Sarcoma? Cell of origin Young F, deep soft tissue PASD: needle-like like crystals EM: membrane-bound bound crystals with cross-grid pattern der(17)t(x;17)(p11.2;q25) TFE3-ASPSCR1 [ASPL] fusion gene

Alveolar Soft Part Sarcoma

55 year old man with an arm mass. What is the diagnosis? A. Leiomyoma B. Schwannoma C. Myxoma D. Palisaded encapsulated neuroma E. Morton s neuroma

Schwannoma Encapsulated (capsule is epineurium) Solitary lesion Benign Location: Head and neck Flexor surfaces of extremities Deep: posterior mediastinum,, retroperitoneum Uniform, intense + with S-100S Antoni A/Antoni Antoni B; ancient changes; characteristic vessels

Schwannoma

This lesion, present since childhood, is pathognomonic for which of the following syndromes? A. Neurofibromatosis type I B. Neurofibromatosis type II C. Von-Hippel Lindau D. Sturge-Weber E. Klippel-Trenaunay

Neurofibroma Not encapsulated Plexiform neurofibroma = diffuse, tortuous enlargement of peripheral nerves Proliferation of all the elements of a nerve: Axons: positive for NSE, neurofilament Schwann cells: positive for S-100S Fibroblasts: positive for CD34, FXIIIa Perineurial cells: positive for EMA

Neurofibromatosis NF1 Very common: 1:2,500/3,000 Autosomal dominant NF1 gene (crz( crz.. 17) encodes neurofibromin Multiple neurofibromas, plexiform neurfibroma,, >5 café au lait spots, other malformations 5-13% develop MPNST NF2 NF2 gene (crz( 22) encodes merlin Bilateral acoustic schwannomas,, other CNS neoplasms (meningioma, astrocytoma)

3 yo girl with arrhythmia was found to have a cardiac mass. The following is true about this lesion with the EXCEPTION: A. This is a lesion of infants and small children B. Can be associated with tuberous sclerosis C. This lesion may regress spontaneously D. The lesional cells are called spider cells E. This lesion may transform into malignancy

Rhabdomyoma Cardiac Extracardiac 1. Adult type Head and neck, elderly people 2. Fetal type Head and neck, children 3. Genital type Polypoid mass in vagina/vulva of middle- aged women Spider cell

14 yo girl with a leg mass. Tumor cells were positive for myo-d1 (see image). The following is TRUE about this tumor: A. Genitourinary tract is a common location for this tumor. B. It is characterized by PAX3- FKHR fusion gene. C. Positivity with myo-d1 is sensitive but not very specific for this tumor. D. This tumor has a favorable histology E. This tumor is more common in adult population.

Alveolar RMS Desmin

Embryonal RMS, spindle cell type